[{"address1": "Level 10", "address2": "Tower 11 Avenue 5, No. 8 Jalan Kerinchi", "city": "Kuala Lumpur", "zip": "592000", "country": "Malaysia", "phone": "60 9 08517 7330", "website": "https://www.cyclacel.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis control biology in the United States. Its lead product Plogosertib or plogo, a solid tumors and hematological malignancies, which is in Phase 1/2 clinical trial. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Sing Ee Wong", "age": 43, "title": "Chairman, CEO & President", "yearBorn": 1981, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Cu Seng Kiu", "age": 34, "title": "Executive Director, CFO & Secretary", "yearBorn": 1990, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Gill  Christie", "age": 67, "title": "Director of Human Resources", "yearBorn": 1957, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Grace  Kim", "title": "Investor Relations Executive", "exercisedValue": 0, "unexercisedValue": 0}], "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 6.77, "open": 6.76, "dayLow": 6.1, "dayHigh": 6.96, "regularMarketPreviousClose": 6.77, "regularMarketOpen": 6.76, "regularMarketDayLow": 6.1, "regularMarketDayHigh": 6.96, "payoutRatio": 0.0, "beta": 0.156, "trailingPE": 0.0008935214, "forwardPE": -3.1984923, "volume": 219909, "regularMarketVolume": 219909, "averageVolume": 1864684, "averageVolume10days": 133210, "averageDailyVolume10Day": 133210, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 14251107, "fiftyTwoWeekLow": 3.08, "fiftyTwoWeekHigh": 597.6, "priceToSalesTrailing12Months": 1425.1107, "fiftyDayAverage": 8.529, "twoHundredDayAverage": 49.48125, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 9216684, "profitMargins": 0.0, "floatShares": 14643, "sharesOutstanding": 2238980, "sharesShort": 96283, "sharesShortPriorMonth": 101016, "sharesShortPreviousMonthDate": 1753920000, "dateShortInterest": 1756425600, "sharesPercentSharesOut": 0.043, "heldPercentInsiders": 0.79466003, "heldPercentInstitutions": 0.00795, "shortRatio": 0.5, "shortPercentOfFloat": 0.0674, "impliedSharesOutstanding": 2238980, "bookValue": 2.29, "priceToBook": 2.779476, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -6428000, "trailingEps": 7123.5, "forwardEps": -1.99, "lastSplitFactor": "1:15", "lastSplitDate": 1751846400, "enterpriseToRevenue": 921.668, "enterpriseToEbitda": -0.89, "52WeekChange": -0.9756473, "SandP52WeekChange": 0.16885936, "quoteType": "EQUITY", "currentPrice": 6.365, "recommendationKey": "none", "totalCash": 4275000, "totalCashPerShare": 1.909, "ebitda": -10355000, "totalDebt": 10000, "quickRatio": 5.625, "currentRatio": 5.767, "totalRevenue": 10000, "debtToEquity": 0.275, "revenuePerShare": 0.006, "returnOnAssets": -1.0283101, "returnOnEquity": -2.7680302, "grossProfits": 10000, "freeCashflow": -9424750, "operatingCashflow": -8726000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -1035.8, "financialCurrency": "USD", "symbol": "CYCC", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1079447400000, "regularMarketChange": -0.405, "regularMarketDayRange": "6.1 - 6.96", "fullExchangeName": "NasdaqCM", "corporateActions": [{"header": "Ticker Change", "message": "CYCC is trading under new symbol BGMS effective Sep. 12, 2025", "meta": {"eventType": "TICKER_CHANGE", "dateEpochMs": 1757649600000, "newTicker": "BGMS"}}], "regularMarketTime": 1757620800, "exchange": "NCM", "messageBoardId": "finmb_125004", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -5.98228, "regularMarketPrice": 6.365, "marketState": "CLOSED", "shortName": "Cyclacel Pharmaceuticals, Inc.", "longName": "Cyclacel Pharmaceuticals, Inc.", "averageDailyVolume3Month": 1864684, "fiftyTwoWeekLowChange": 3.2849998, "fiftyTwoWeekLowChangePercent": 1.0665584, "fiftyTwoWeekRange": "3.08 - 597.6", "fiftyTwoWeekHighChange": -591.235, "fiftyTwoWeekHighChangePercent": -0.98934907, "fiftyTwoWeekChangePercent": -97.56473, "dividendDate": 1746057600, "earningsTimestampStart": 1754996340, "earningsTimestampEnd": 1755518400, "earningsCallTimestampStart": 1723667400, "earningsCallTimestampEnd": 1723667400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 7123.5, "epsForward": -1.99, "fiftyDayAverageChange": -2.1640005, "fiftyDayAverageChangePercent": -0.25372264, "twoHundredDayAverageChange": -43.11625, "twoHundredDayAverageChangePercent": -0.87136537, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "displayName": "Cyclacel Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-09-13"}]